Kirjoita osake tai kryptovaluutta hakupalkkiin saadaksesi yhteenvedon
Supriya Lifescience Limited
SUPRIYASupriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti"hypertensive, anti-malarial products, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products. In addition, it also offers GelHeal, a wound care solution; and Quickblue, an oral cancer detection kit. Further, the company is developing drugs in the areas of anti-depressant, anti-inflammatory, contrast media, hormones, antibiotic, smoking cessasion, anti-diabetic/obesity, anti-ataxia, decongestant, veterinary API, anti-cancer, allogeneic hematopoietic, stem cell transplantation, and anti-migraine. The company was founded in 1987 and is headquartered in Mumbai, India. Address: 207/208 Udyog Bhavan, Mumbai, India, 400063
Analytics
WallStreetin tavoitehinta
48 126.95 INRP/E-suhde
33.2291Osinkotuotto
0.13 %Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Kuluva vuosi
Edellinen vuosi
Nykyinen vuosineljännes
Viimeinen vuosineljännes
Avainluvut SUPRIYA
Osinkoanalytiikka SUPRIYA
Osinkojen kasvu 5 vuoden aikana
–Jatkuva kasvu
1 vuosiMaksusuhde 5 vuoden keskiarvo
4 %Osinkohistoria SUPRIYA
Osakkeen arvostus SUPRIYA
Talousasiat SUPRIYA
Tuloksia | 2019 | Dynamiikka |